Repurposing Drugs as Potential Therapeutics for the SARS-Cov-2 Viral Infection: Automatizing a Blind Molecular Docking High-throughput Pipeline
In the context of the COVID-19 pandemic, scientists worldwide have been looking for ways to stop it using different approaches. One strategy is to look among drugs that have already proved safe for use in humans and tested for other illnesses. Several components from the virus and the infected cell...
Guardado en:
| Autores principales: | , , |
|---|---|
| Formato: | Capítulo de libro |
| Lenguaje: | inglés |
| Publicado: |
IntechOpen
2022
|
| Materias: | |
| Acceso en línea: | https://www.intechopen.com/chapters/82800 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares: Repurposing Drugs as Potential Therapeutics for the SARS-Cov-2 Viral Infection: Automatizing a Blind Molecular Docking High-throughput Pipeline
- An in silico drug repurposing pipeline to identify drugs with the potential to inhibit SARS-CoV-2 replication
- Drug Repurposing: Challenges and Successes in the Treatment of SARS-CoV-2
- Drug Repurposing Techniques in Viral Diseases
- Applications of Molecular Docking Techniques in Repurposing of Drug
- Evaluation of Drug Repositioning by Molecular Docking of Pharmaceutical Resources to Identification of Potential <em>SARS-CoV-2</em> Viral Inhibitors
- Role of Anti-Viral Drugs in Combating SARS-CoV-2